Geovax Labs (GOVX)

Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
March 7, 2024
Report ID: 26577
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Geovax Labs
Geovax Labs
Healthcare
Biotechnology
Ticker
GOVX
Current Price
$2.8 -4.11%
Market Cap
$6.5M
Price Target
Refer to Report
Volume
259.2K
52wk Range
$1.0901 - $10.2405
Related Research Reports
7/10/2024

Looking Forward To Continued Progress In 2H24
Looking Forward To Continued Progress In 2H24 (GOVX)
6/28/2024

CRO Partnership For Clinical Trial Allows Sponsored Phase 2b Trial To Move Forward
CRO Partnership For Clinical Trial Allows Sponsored Phase 2b Trial To Move Forward (GOVX)
6/18/2024

GeoVax Receives BARDA Award For COVID Vaccine Trial
GeoVax Receives BARDA Award For COVID Vaccine Trial (GOVX)
5/15/2024

1Q24 Reported With Clinical Milestones Later In FY2024
1Q24 Reported With Clinical Milestones Later In FY2024 (GOVX)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy